1-3 of 3
Huilai Zhang
Close
Sort by
Journal Articles

Treating relapsed/refractory mature T- and NK-cell neoplasms with tislelizumab: a multicenter open-label phase 2 study

Clinical Trials & Observations
Emmanuel Bachy, Kerry J. Savage, Huiqiang Huang, Yok-Lam Kwong, Giuseppe Gritti, Qingyuan Zhang, Anna Marina Liberati, Junning Cao, Haiyan Yang, Siguo Hao, Jianda Hu, Keshu Zhou, Mario Petrini, Filomena Russo, Huilai Zhang, Wei Sang, Jie Ji, Andrés José María Ferreri, Gandhi Laurent Damaj, Hui Liu, Wei Zhang, Xiaoyan Ke, Chiara Ghiggi, Sha Huang, Xiaotong Li, Hui Yao, Jason Paik, William Novotny, Wenxiao Zhou, Hongjie Zhu, Pier Luigi Zinzani
Journal: Blood Advances
Blood Adv (2023) 7 (16): 4435–4447.
https://doi.org/10.1182/bloodadvances.2022009575
Published: 2023
Includes: Supplemental data
Journal Articles

Distinct clinical and genetic features of hepatitis B virus–associated follicular lymphoma in Chinese patients

Weicheng Ren, Xianhuo Wang, Mingyu Yang, Hui Wan, Xiaobo Li, Xiaofei Ye, Bing Meng, Wei Li, Jingwei Yu, Mengyue Lei, Fanfan Xie, Wenqi Jiang, Eva Kimby, Huiqiang Huang, Dongbing Liu, Zhi-Ming Li, Kui Wu, Huilai Zhang, Qiang Pan-Hammarström
Journal: Blood Advances
Blood Adv (2022) 6 (9): 2731–2744.
https://doi.org/10.1182/bloodadvances.2021006410
Published: 2022
Includes: Supplemental data
Journal Articles

Zanubrutinib monotherapy for relapsed or refractory non-germinal center diffuse large B-cell lymphoma

Clinical Trials & Observations
Haiyan Yang, Bing Xiang, Yuqin Song, Huilai Zhang, Weili Zhao, Dehui Zou, Fangfang Lv, Wei Guo, Aichun Liu, Caixia Li, Ziwen Tan, Yang Liu, Lina Fu, Haiyi Guo, William Novotny, Jane Huang, Yufu Li
Journal: Blood Advances
Blood Adv (2022) 6 (6): 1629–1636.
https://doi.org/10.1182/bloodadvances.2020003698
Published: 2022
Includes: Supplemental data